compound tirzepatide injections Injection for Seniors With Medicare Compounded Tirzepatide (GLP-1/GIP)

Pharmaceuticals , 16

Therapeutic strategies for Alzheimers disease in the view of Diabetes Mellitus

FDA-APPROVED INDICATIONS Type 2 diabetes As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus Limitations of use: has not been studied in patients with a history of pancreatitis TYPE 2 DIABETES RCT SURPASS-2 trial - Tirzepatide vs Semaglutide in Patients with Type 2 Diabetes, NEJM (2021) [PubMed abstract] The SURPASS-2 trial enrolled 1879 adults with type 2 diabetes who were inadequately controlled with metformin at a dose of at least 1500 mg per day Main inclusion criteria Age 18 years T2DM uncontrolled with metformin at 1500 mg/day A1C of 7 - 10.5% BMI 25 and stable for 3 months Main exclusion criteria Type 1 diabetes GFR 50 ng/L

3-4 , 8 ,

By managing your thyroid health proactively, you ensure that when you do walk into that clinic, you are doing so from a place of strength

Key Dosing Differences MT-1 doesn't need a titration phase side effects are mild enough to start at full dose MT-2 loading is daily